中图分类号:
解卫平. 2020年《欧洲呼吸学会慢性血栓栓塞性肺动脉高压的专家共识》解读[J]. 实用老年医学, 2021, 35(6): 660-664.
| [1] GALIE N, HUMBERT M, VACHIERY J L, et al. 2015 ESC/ERS Guidelines for thediagnosis and treatment of pulmonary hypertension[J]. Eur Respir J, 2015, 46(4): 903-975. [2] PEPKE-ZABA J, DELCROIX M, LANG I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry[J]. Circulation, 2011, 124(18): 1973-1981. [3] CAMPEAN IA, LANG IM. Treating pulmonary hypertension in the elderly[J]. Expert Opin Pharmacother Actions, 2020, 21(10):1193-1200. [4] DELCROIX M, TORBICKI A, GOPALAN D, et al. ERS Statement on Chronic Thromboembolic Pulmonary Hypertension[J]. Eur Respir J, 2020. doi: 10.1183/13993003.02828-2020. [5] KIM N H, DELCROIX M, JAIS X, et al. Chronic thromboembolic pulmonary hypertension[J]. Eur Respir J, 2019, 53(1): 1801915. [6] SIMONNEAU G, MONTANI D, CELERMAJER D S, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension[J]. Eur Respir J, 2019, 53(1): 1801913. [7] GERCHE A, PETIT T, BELGE C, et al. Impaired cardiac reserve and abnormal vascular load limit exercise capacity in chronic thromboembolic disease[J]. JACC Cardiovasc Imaging, 2019, 12(8): 1444-1456. [8] GUTH S, WIEDENROTH C B, RIETH A, et al. Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease[J]. Eur Respir J, 2018, 52(3): 1800458. [9] ZHAO Q H, WANG L, PUDASAINI B, et al. Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension[J]. Clin Cardiol, 2017, 40(2): 95-101. [10]BOULATE D, PERROS F, DORFMULLER P, et al. Pulmonary microvascular lesions regress in reperfused chronic thromboembolic pulmonary hypertension[J]. J Heart Lung Transplant, 2015, 34(3): 457-467. [11]KAN Y, YUAN L, MEEKS J K, et al. The accuracy of V/Q SPECT in the diagnosis of pulmonary embolism: a meta-analysis[J]. Acta Radiol, 2015, 56(5): 565-572. [12]GIORDANO J, KHUNG S, DUHAMEL A, et al. Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH): Dual-energy CT experience in 31 patients[J]. Eur Radiol, 2016, 27(4): 1631-1639. [13]KIM S S, HUR J, KIM Y J, et al. Dual-energy CT for differentiating acute and chronic pulmonary thromboembolism: an initial experience[J]. Int J Cardiovasc Imaging, 2014, 30 Suppl 2: 113-120. [14]RAJARAM S, RAJARAM S, SWIFT A J, et al. 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry[J]. Thorax, 2013, 68(7): 677-678. [15]ENDE-VERHAAR Y M, CANNEGIETER S C, VONK-NOORDEGRAAF A, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature[J]. Eur Respir J, 2017, 49(2): 1601792. [16]MENEVEAU N, IDER O, SERONDE M F, et al. Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism[J]. Eur Heart J, 2013, 34(9): 693-701. [17]LEWCZUK J, PISZKO P, JAGAS J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism[J]. Chest, 2001, 119(3): 818-823. [18]KONSTANTINIDES S V, MEYER G, BECATTINI C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)[J]. Eur Heart J, 2020, 41(4): 543-603. [19]HUMBERT M, GUIGNABERT C, BONNET S, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives[J]. Eur Respir J, 2019, 53(1): 1801887. [20]MOSER K M, BLOOR C M. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension[J]. Chest, 1993, 103(3): 685-692. [21]MENZEL T, WAGNER S, KRAMM T, et al. Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy[J]. Chest, 2000, 118(4): 897-903. [22]MADANI M, OGO T, SIMONNEAU G. The changing landscape of chronic thromboembolic pulmonary hypertension management[J]. Eur Respir Rev, 2017, 26(146): 170105. [23]GHOFRANI H A, D'ARMINI A M, GRIMMINGER F, et al. CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension[J]. N Engl J Med, 2013, 369(4): 319-329. [24]WIEDENROTH C B, GHOFRANI H A, ADAMEIT M S D, et al. Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension[J]. Pulm Circ, 2018, 8(3): 2045894018783996. [25]EHLKEN N, LICHTBLAU M, KLOSE H, et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial[J]. Eur Heart J, 2016, 37(1): 35-44. [26]INAGAKI T, TERADA J, TANABE N, et al. Home-based pulmonary rehabilitation in patients with inoperable or residual chronic thromboembolic pulmonary hypertension: a preliminary study[J]. Respir Investig, 2014, 52(6): 357-364. |
| [1] | 周赟, 张影影, 高妍芬. 肺力咳合剂联合噻托溴铵粉雾剂在高龄慢性阻塞性肺疾病病人中的效果观察[J]. 实用老年医学, 2024, 38(10): 1011-1015. |
| [2] | 雷万锋, 马秀红. 老年COPD急性加重期病人血清IL-33/sST2轴表达及其对预后的预测价值[J]. 实用老年医学, 2024, 38(10): 1044-1048. |
| [3] | 徐金燕, 夏聪聪, 杨红美. 老年脑卒中肺部感染风险预测模型的建立及验证[J]. 实用老年医学, 2024, 38(5): 452-437. |
| [4] | 彭泽通, 张尧, 刘斌. 贫血对老年社区获得性肺炎死亡的影响分析[J]. 实用老年医学, 2024, 38(3): 260-264. |
| [5] | 苏雪姣, 刘月, 孙蜀宁. 高龄新型冠状病毒感染老年人外周血液学指标与预后的相关性[J]. 实用老年医学, 2024, 38(3): 291-292. |
| [6] | 张杰斯, 黎艳聪, 卢钻芬, 李明标. 黏液玫瑰单胞菌致COPD急性加重1例及文献分析[J]. 实用老年医学, 2024, 38(3): 322-324. |
| [7] | 王瑞萍, 张妮. COPD病人一氧化碳弥散量与运动耐力、呼吸困难及通气效率的相关性研究[J]. 实用老年医学, 2024, 38(2): 141-144. |
| [8] | 姬泽萱, 冯平, 李峰, 项保利, 冯改霞. 老年男性COPD合并骨质疏松病人睾酮及FGF23、MMP-9水平的变化[J]. 实用老年医学, 2024, 38(2): 176-178. |
| [9] | 周柳青, 周计雪, 柳毅. 抑郁症病人抗抑郁药物治疗中2次发生肺栓塞:2例报道[J]. 实用老年医学, 2024, 38(2): 203-205. |
| [10] | 秦克, 李同林, 华俊萍, 江美芳. 老年COPD稳定期病人经鼻高流量湿化氧疗血清颗粒蛋白前体表达水平及意义[J]. 实用老年医学, 2023, 37(12): 1215-1218. |
| [11] | 李娜, 叶莹, 王鸿林, 周秋红. 老年新型冠状病毒感染病人营养支持的研究进展[J]. 实用老年医学, 2023, 37(11): 1081-1075. |
| [12] | 郭佳丽, 黄淳, 陶子荣, 彭伶丽. 老年新型冠状病毒感染病人俯卧位通气管理的最佳证据总结[J]. 实用老年医学, 2023, 37(11): 1086-1091. |
| [13] | 王雪敬, 邓宝凤, 罗昌春, 赵玉荣, 张爱军, 刘海荣, 赵艳梅. 新型冠状病毒感染期间远程探视系统在老年肿瘤住院病人中的应用[J]. 实用老年医学, 2023, 37(11): 1095-1098. |
| [14] | 陈秋羽, 王展展, 李春华. 肠道菌群相关短链脂肪酸在COPD发病机制中的作用研究进展[J]. 实用老年医学, 2023, 37(11): 1166-1169. |
| [15] | 王世福, 欧宗兴, 符沙沙. 老年COPD相关肺动脉高压病人血管活性肠肽水平及其与高凝、低氧状态和血管内皮功能的相关性[J]. 实用老年医学, 2023, 37(9): 907-910. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
|
